期刊文献+

白血病患者化疗前后吲哚胺2,3-双加氧酶活性变化及意义 被引量:2

下载PDF
导出
摘要 目的探讨吲哚胺2,3-双加氧酶(IDO)活性在白血病患者化疗前后的差异及其临床意义。方法采用在线衍生高效液相色谱荧光法(HPLC-FLD)检测30例白血病患者化疗前后犬尿氨酸(KYN)和色氨酸(TRP)的浓度,计算IDO活性,并与正常对照组比较。结果化疗前白血病患者TRP、KYN水平、K/T比值与正常对照组比较,差异有统计学意义(P<0.05);化疗后白血病患者TRP、KYN水平、K/T比值与化疗前比较,差异有统计学意义(P<0.05)。化疗前、后白血病患者K/T比值均与WBC呈正相关(r=0.924,P<0.01;r=0.779,P<0.01)。结论白血病化疗治疗可能影响白血病患者血清中IDO活性,从而影响TRP、KYN代谢,IDO活性可能与白血病发病、疗效和复发相关。
出处 《广东医学》 CAS CSCD 北大核心 2013年第10期1584-1586,共3页 Guangdong Medical Journal
  • 相关文献

参考文献13

  • 1PRENDERGAST G C. Immune escape as a fundamental trait of cancer: focus on IDO[J]. Oncogene, 2008, 28(27): 3889- 3990.
  • 2孙静昕,张王刚,陈银霞,赵万红,田玮,杨云,刘苏虎.吲哚胺2,3-二氧化酶在人急性单核细胞白血病(M_5)和急性淋巴细胞白血病细胞中的表达及其抑制剂1-甲基色氨酸的治疗作用(英文)[J].中国实验血液学杂志,2007,15(3):478-482. 被引量:5
  • 3MOFFETI? J R, NAMBOODIRI M A. Tryptophan and the immune response[J]. Immunol Cell Biol, 2003, 81(4):247-265.
  • 4SCHWARCZ R. The Kynurenine pathway of tryptophan degrada- tion as a drag target [ J ]. Curt Opin Pharmacol, 2004, 4 ( 1 ) : 12 - 17.
  • 5TAYLOR M W, FENG G S. Relationship between interferon - γ, indoleamine 2, 3 - dioxygenase, and tryptophan catabolism [ J ]. FASEB J, 1991,5(11) : 2516 -2522.
  • 6UYTTENHOVE C, POLOTTO L, THEATE I, et al. Evidence for a tumoral jm. muneresistance mechanism based on tryptophan deg- radation by indoleamine 2, 3 - dioxygenase [ J ]. Nat Med, 2003, 9(10) : 1269 -1274.
  • 7TERNESS P, CHUANG J, BAUER T, et al. Regulation of human auto - and alloreactive T cells by indoleamine 2, 3 - dioxygenase (IDO) -producing dendritic ceils: too much ado about IDO? [J]. Blood, 2005, 105(6): 2480-2486.
  • 8CORM S, BERTHON C, IMBENOTTE M, et al. Indoleamine 2, 3- dioxygenase activity of acute myeloid leukemia cells can be measured from patients $ era by HPLC and is inducible by IFN - γ [J]. Leuk Res, 2009, 33(3) : 490 -494.
  • 9HOSHI M, ITO H, FUJIGAKI H, et al. Indoleamine 2, 3 - diox- ygenase is highly expressed in human adult T - cell leukemia/lym- phoma and chemotherapy changes tryptophan catabolism in serum and reduced activityty[J]. Leuk Res, 2009, 33(1): 39-45.
  • 10FUJIGAKI H, SAITO K, FUJIGAKI S, et al. The signal trans- ducer and activator of transcription 1 alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2, 3 - dioxygenase by lipopolysaeeharide: involvement of p38 mitogen - activated protein kinase and nuclear factor - κB pathways, and synergistic effect of several pro-inflammatory cytokines[J]. Bio- ehem, 2006, 139(4): 655-662.

二级参考文献4

  • 1Uyttenhove C,Pilotte L,Theate I,et al.Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.Nat Med,2003;9:1269-1274
  • 2Sakurai K,Enomoto K,Amano S,et al.Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma.Gan To Kagaku Ryoho,2004;31:1780-1782
  • 3Grohmann U,Fallarino F,Puccetti P.Tolerance,DCs and tryptophan:much ado about IDO.Trends Immunol,2003;24:242-248
  • 4Munn DH,Mellor AL.IDO and tolerance to tumors.Trends Mol Med,2004;10:15-18

共引文献4

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部